A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II
NCT: NCT02890160 · COMPLETED
NCT IDNCT02890160
StatusCOMPLETED
Start Date2017-08-24
Completion2024-10-03
Brief Summary
The FUTURE-II study is a confirmative clinical trial for Sirolimus Target Eluting Bioresorbable Vascular Scaffold (Firesorb) after the feasibility and safety of the device has been preliminary confirmed in a small-scale First-in-Man clinical trial.
Frequently Asked Questions
What is A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II?
A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II is a clinical trial registered under NCT02890160. Current status: COMPLETED.
What is the status of NCT02890160?
The current status of NCT02890160 (A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II) is: COMPLETED.
When did A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II start?
A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II started on 2017-08-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.